REZOLUTE, INC.

Profile

Company Names

REZOLUTE, INC.
ANTRIABIO, INC.
FITS MY STYLE INC

Addresses

201 REDWOOD SHORES PKWY, SUITE 315, REDWOOD CITY, CA 94065

1450 INFINITE DRIVE, LOUISVILLE, CO 80027

890 SANTA CRUZ AVENUE, MENLO PARK, CA 94025

9A YADIN IGAL STREET, RA-ANANA, L3 43582

Phone Numbers

(650) 206-4507
(303) 222-2128
650-847-1919
650-241-9330
+972 9 774 8757

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2010

State Incorporated:

NEVADA

Total Amount Raised:

$85,001,219.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2020-10-09 
$41,000,000.00 
$56,990,020.00 
$15,990,020.00 
Equity 
11
2018-01-30 
$4,800,000.00 
$6,000,000.00 
$1,200,000.00 
Debt 
10
2017-12-22 
$137,868.00 
$10,137,868.00 
$10,000,000.00 
Equity 
9
2017-03-06 
$6,726,190.00 
$15,000,000.00 
$8,273,810.00 
Equity 
8
2017-01-31 
$3,360,000.00 
$25,431,894.00 
$22,071,894.00 
Equity 
7
2016-06-24 
$5,362,521.00 
$53,300,000.00 
$47,937,479.00 
Equity 
6
2015-12-10 
$4,347,615.00 
$16,709,995.00 
$12,362,380.00 
Equity 
5
2015-03-31 
$1,984,012.00 
$4,702,703.00 
$2,718,691.00 
Equity 
4
2014-11-28 
$6,925,580.00 
$35,270,270.00 
$28,344,690.00 
Equity 
3
2014-03-31 
$8,931,433.00 
$26,250,000.00 
$17,318,567.00 
Equity 
2
2013-12-23 
$1,420,000.00 
$3,500,000.00 
$2,080,000.00 
Debt 
1
2010-10-01 
$6,000.00 
$6,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NIR 
 
BAR 
DIRECTOR, EXECUTIVE OFFICER
FITS MY STYLE INC
MICHAEL 
R. 
DEPERRO 
EXECUTIVE OFFICER
ANTRIABIO, INC.   |  REZOLUTE, INC.
NEVAN 
 
ELAM 
EXECUTIVE OFFICER, DIRECTOR
SAVARA INC.   |  ANTRIABIO, INC.   |  SAVARA INC
NEVAN 
CHARLES 
ELAM 
EXECUTIVE OFFICER, DIRECTOR
ANTRIABIO, INC.   |  REZOLUTE, INC.
PHILIPPE 
 
FAUCHET 
DIRECTOR
REZOLUTE, INC.
MORGAN 
LYNN 
FIELDS 
EXECUTIVE OFFICER
ANTRIABIO, INC.   |  REZOLUTE, INC.
STEVE 
R. 
HOWE 
DIRECTOR
ANTRIABIO, INC.   |  DRYWAVE TECHNOLOGIES USA, INC.   |  ANTRIABIO, INC.
HOYOUNG 
 
HUH 
EXECUTIVE OFFICER, DIRECTOR
CALIBRA MEDICAL, INC.   |  JENNEREX, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ANTRIABIO, INC.   |  RESET THERAPEUTICS, INC.   |  NUVESSE SKIN THERAPIES, INC.   |  JUUL LABS, INC.   |  REZOLUTE, INC.   |  EIDOS THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  AKARI THERAPEUTICS PLC
TAE 
HOON 
KIM 
DIRECTOR
ANTRIABIO, INC.   |  REZOLUTE, INC.   |  SURFF INC.
YOUNG-JIN 
 
KIM 
DIRECTOR
REZOLUTE, INC.
GIL 
 
LABRUCHERIE 
DIRECTOR
REZOLUTE, INC.
NOOPUR 
BATSHA 
LIFFICK 
EXECUTIVE OFFICER
ANTRIABIO, INC.   |  REZOLUTE, INC.
JUNG-HEE 
 
LIM 
DIRECTOR
REZOLUTE, INC.
SANKARAM 
 
MANTRIPRAGADA 
EXECUTIVE OFFICER
ANTRIABIO, INC.   |  REZOLUTE, INC.
SAMIR 
R. 
PATEL 
DIRECTOR
ANTRIABIO, INC.   |  REZOLUTE, INC.
BRIAN 
 
ROBERTS 
EXECUTIVE OFFICER
PIPELINE HEALTH HOLDINGS LLC   |  TOSCA MINING CORP   |  WARNER MUSIC GROUP CORP.   |  CELLAEGIS DEVICES INC.   |  INFINITY MINERALS CORP.   |  TOSCA RESOURCES CORP   |  ANTRIABIO, INC.   |  REZOLUTE, INC.   |  TARVEDA THERAPEUTICS, INC.   |  1292267 B.C., LTD.   |  OZONE NETWORKS, INC.
BARRY 
 
SHERMAN 
DIRECTOR
JENNEREX, INC.   |  ANTRIABIO, INC.
GUY 
 
TURNOWSKI 
DIRECTOR
FITS MY STYLE INC
KEITH 
 
VENDOLA 
EXECUTIVE OFFICER
EIGER BIOPHARMACEUTICALS INC   |  REZOLUTE, INC.   |  WUGEN, INC.
DAVID 
 
WELCH 
DIRECTOR
WRIGHTSPEED, INC.   |  ANTRIABIO, INC.   |  ZAPGO LTD.   |  NAVUS FUND LLC   |  ATTOTUDE INC.
DAVID 
F. 
WELCH 
DIRECTOR
ANTRIABIO, INC.   |  REZOLUTE, INC.   |  INFINERA CORP   |  CYTODYN INC.   |  AXIADO CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-10-09 
2018-04-24
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-01-30 
2018-02-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-01-30 
2018-02-07
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-31 
2018-01-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-22 
2017-05-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-03-06 
2017-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-31 
2016-07-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-24 
2016-03-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-10 
2015-12-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-10 
2015-04-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-31 
2015-01-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-11-28 
2014-04-28
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-31 
2014-04-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-31 
2014-01-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-12-23 
2011-05-17
D
Link
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2010-10-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CANACCORD GENUITY CORP.
NONE
CANACCORD GENUITY LLC
1020
NONE
NONE
JMP SECURITIES LLC
22208
NONE
NONE
GRIFFIN SECURITIES, INC.
43229
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF CIM SECURITIES, LLC
120852
CIM SECURITIES, LLC
120852
BROOKLINE CAPITAL MARKETS
NONE
NONE
NONE
PAULSON INVESTMENT COMPANY, INC.
5670
NONE
NONE
BROOKLINE GROUP, LLC
153587
NONE
NONE
PAULSON INVESTMENT COMPANY, INC.
5670